BRIEF

on REPLOID Group AG (isin : AT0000A3HRX5)

REPLOID Group AG Forms Joint Venture with PreZero for Insect Protein Production

REPLOID Group AG has announced a joint venture with PreZero Stiftung & Co. KG to focus on insect protein production. This collaboration will leverage REPLOID's ReFarmUnit technology, with the facility expected to be operational by 2027 in Buchen, Germany. The partnership plans to industrially process Black Soldier Fly larvae, transforming them into products like fresh insect slurry and hydrolyzed protein primarily for the animal feed industry.

The joint venture's ownership stakes have been revised, now with PreZero holding 75.1% and REPLOID 24.9%. This strategic alliance aims to tap into the growing market of alternative proteins within the circular economy framework while maintaining both companies' independence in their core operations.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all REPLOID Group AG news